SAB Biotherapeutics, Inc. (SABS)
4.54
-0.05
(-1.09%)
USD |
NASDAQ |
Mar 13, 09:38
SAB Biotherapeutics Market Cap : 216.14M for March 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Acumen Pharmaceuticals, Inc. | 201.10M |
| ACADIA Pharmaceuticals, Inc. | 3.661B |
| Agenus, Inc. | 111.68M |
| Alnylam Pharmaceuticals, Inc. | 41.79B |
| Savara, Inc. | 1.091B |
Market Cap Related Metrics
| Price to Book Value | 1.427 |
| Price | 4.54 |
| Earnings Yield | -58.89% |